|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Visvader JE: Cells of origin in cancer.
Nature. 469:314–322. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Easwaran H, Tsai HC and Baylin SB: Cancer
epigenetics: Tumor heterogeneity, plasticity of stem-like states,
and drug resistance. Mol Cell. 54:716–727. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kreso A and Dick JE: Evolution of the
cancer stem cell model. Cell Stem Cell. 14:275–291. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu C, Kelnar K, Liu B, Chen X,
Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, et
al: The microRNA miR-34a inhibits prostate cancer stem cells and
metastasis by directly repressing CD44. Nat Med. 17:211–215. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Muthukrishnan SD, Alvarado AG and Kornblum
HI: Building bonds: Cancer stem cells depend on their progeny to
drive tumor progression. Cell Stem Cell. 22:473–474. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu C, Liu L, Chen X, Cheng J, Zhang H,
Shen J, Shan J, Xu Y, Yang Z, Lai M and Qian C: Sox9 regulates
self-renewal and tumorigenicity by promoting symmetrical cell
division of cancer stem cells in hepatocellular carcinoma.
Hepatology. 64:117–129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang L, Sun H, Zhao F, Lu P, Ge C, Li H,
Hou H, Yan M, Chen T, Jiang G, et al: BMP4 administration induces
differentiation of CD133+ hepatic cancer stem cells,
blocking their contributions to hepatocellular carcinoma. Cancer
Res. 72:4276–4285. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang KH, Ma S, Lee TK, Chan YP, Kwan PS,
Tong CM, Ng IO, Man K, To KF, Lai PB, et al: CD133+
liver tumor-initiating cells promote tumor angiogenesis, growth,
and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
Hepatology. 55:807–820. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai
P, Chu PW, Lam CT, Poon RT and Fan ST: Significance of
CD90+ cancer stem cells in human liver cancer. Cancer
Cell. 13:153–166. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mani SK, Zhang H, Diab A, Pascuzzi PE,
Lefrançois L, Fares N, Bancel B, Merle P and Andrisani O:
EpCAM-regulated intramembrane proteolysis induces a cancer stem
cell-like gene signature in hepatitis B virus-infected hepatocytes.
J Hepatol. 65:888–898. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Haraguchi N, Ishii H, Mimori K, Tanaka F,
Ohkuma M, Kim HM, Akita H, Takiuchi D, Hatano H, Nagano H, Barnard
GF, et al: CD13 is a therapeutic target in human liver cancer stem
cells. J Clin Invest. 120:3326–3339. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Christ B, Stock P and Dollinger MM: CD13:
Waving the flag for a novel cancer stem cell target. Hepatology.
53:1388–1390. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kawai T, Yasuchika K, Ishii T, Katayama H,
Yoshitoshi EY, Ogiso S, Kita S, Yasuda K, Fukumitsu K, Mizumoto M,
et al: Keratin 19, a cancer stem cell marker in human
hepatocellular carcinoma. Clin Cancer Res. 21:3081–3091. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang W, Wang C, Lin Y, Liu Q, Yu LX, Tang
L, Yan HX, Fu J, Chen Y, Zhang HL, et al: OV6+
tumor-initiating cells contribute to tumor progression and invasion
in human hepatocellular carcinoma. J Hepatol. 57:613–620. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yamashita T and Wang XW: Cancer stem cells
in the development of liver cancer. J Clin Invest. 123:1911–1918.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chiba T, Kita K, Zheng YW, Yokosuka O,
Saisho H, Iwama A, Nakauchi H and Taniguchi H: Side population
purified from hepatocellular carcinoma cells harbors cancer stem
cell-like properties. Hepatology. 44:240–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Di Leva G, Garofalo M and Croce CM:
MicroRNAs in cancer. Annu Rev Pathol. 9:287–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ladeiro Y, Couchy G, Balabaud C,
Bioulac-Sage P, Pelletier L, Rebouissou S and Zucman-Rossi J:
MicroRNA profiling in hepatocellular tumors is associated with
clinical features and oncogene/tumor suppressor gene mutations.
Hepatology. 47:1955–1963. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Borel F, Konstantinova P and Jansen PL:
Diagnostic and therapeutic potential of miRNA signatures in
patients with hepatocellular carcinoma. J Hepatol. 56:1371–1383.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yan XL, Jia YL, Chen L, Zeng Q, Zhou JN,
Fu CJ, Chen HX, Yuan HF, Li ZW, Shi L, et al: Hepatocellular
carcinoma-associated mesenchymal stem cells promote hepatocarcinoma
progression: Role of the S100A4-miR155-SOCS1-MMP9 axis. Hepatology.
57:2274–2286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chai S, Ng KY, Tong M, Lau EY, Lee TK,
Chan KW, Yuan YF, Cheung TT, Cheung ST, Wang XQ, et al: Octamer
4/microRNA-1246 signaling axis drives Wnt/β-catenin activation in
liver cancer stem cells. Hepatology. 64:2062–2076. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Tang ZY, Ye SL, Liu YK, Chen J, Xue
Q, Chen J, Gao DM and Bao WH: Establishment of cell clones with
different metastatic potential from the metastatic hepatocellular
carcinoma cell line MHCC97. World J Gastroenterol. 7:630–636. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan XL, Fu CJ, Chen L, Qin JH, Zeng Q,
Yuan HF, Nan X, Chen HX, Zhou JN, Lin YL, et al: Mesenchymal stem
cells from primary breast cancer tissue promote cancer
proliferation and enhance mammosphere formation partially via
EGF/EGFR/Akt pathway. Breast Cancer Res Treat. 132:153–164. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Miao X, Yan X, Qu D, Li D, Tao FF and Sun
Z: Red emissive sulfur, nitrogen codoped carbon dots and their
application in ion detection and theraonostics. ACS Appl Mater
Interfaces. 9:18549–18556. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou JN, Zeng Q, Wang HY, Zhang B, Li ST,
Nan X, Cao N, Fu CJ, Yan X, Jia YL, et al: MicroRNA-125b attenuates
epithelial-mesenchymal transitions and targets stem-like liver
cancer cells through small mothers against decapentaplegic 2 and 4.
Hepatology. 62:801–815. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yan X, Zhang D, Wu W, Wu S, Qian J, Hao Y,
Yan F, Zhu P, Wu J, Huang G, et al: Mesenchymal stem cells promote
hepatocarcinogenesis via lncRNA-MUF interaction with ANXA2 and
miR-34a. Cancer Res. 77:6704–6716. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li Y, Tian B, Yang J, Zhao L, Wu X, Ye SL,
Liu YK and Tang ZY: Stepwise metastatic human hepatocellular
carcinoma cell model system with multiple metastatic potentials
established through consecutive in vivo selection and studies on
metastatic characteristics. J Cancer Res Clin Oncol. 130:460–468.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gramantieri L, Ferracin M, Fornari F,
Veronese A, Sabbioni S, Liu CG, Calin GA, Giovannini C, Ferrazzi E,
Grazi GL, et al: Cyclin G1 is a target of miR-122a, a microRNA
frequently down- regulated in human hepatocellular carcinoma.
Cancer Res. 67:6092–6099. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang J, Tian X, Han R, Zhang X, Wang X,
Shen H, Xue L, Liu Y, Yan X, Shen J, et al: Downregulation of
miR-486-5p contributes to tumor progression and metastasis by
targeting protumorigenic ARHGAP5 in lung cancer. Oncogene.
33:1181–1189. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Oh HK, Tan AL, Das K, Ooi CH, Deng NT, Tan
IB, Beillard E, Lee J, Ramnarayanan K, Rha SY, et al: Genomic loss
of miR-486 regulates tumor progression and the OLFM4 antiapoptotic
factor in gastric cancer. Clin Cancer Res. 17:2657–2667. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu L, Liu C, Zhang Q, Shen J, Zhang H,
Shan J, Duan G, Guo D, Chen X, Cheng J, et al: SIRT1-mediated
transcriptional regulation of SOX2 is important for self-renewal of
liver cancer stem cells. Hepatology. 64:814–827. 2016. View Article : Google Scholar : PubMed/NCBI
|
